These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Vigabatrin in epilepsy in mentally retarded patients. Matilainen R, Pitkänen A, Ruutiainen T, Mervaala E, Riekkinen P. Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902 [Abstract] [Full Text] [Related]
26. Effect of long-term vigabatrin therapy on GABA and other amino acid concentrations in the central nervous system--a case study. Ben-Menachem E, Hamberger A, Mumford J. Epilepsy Res; 1993 Dec; 16(3):241-3. PubMed ID: 8119275 [Abstract] [Full Text] [Related]
31. Effects of long-term vigabatrin on somatosensory-evoked potentials in epileptic patients. Liegeois-Chauvel C, Marquis P, Gisselbrecht D, Pantieri R, Beaumont D, Chauvel P. Epilepsia; 1989 Dec; 30 Suppl 3():S23-5. PubMed ID: 2767016 [Abstract] [Full Text] [Related]
32. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and gamma-vinyl-gamma-aminobutyric acid (gamma-vinyl GABA) alter neurotransmitter concentrations in the nervous tissue of the goldfish (Carassius auratus) but not the cockroach (Periplaneta americana). Sloley BD, McKenna KF. Neurochem Int; 1993 Feb; 22(2):197-203. PubMed ID: 8094992 [Abstract] [Full Text] [Related]
35. A controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia. Bonnet AM, Esteguy M, Tell G, Schechter PJ, Hardenberg J, Agid Y. Can J Neurol Sci; 1986 Nov; 13(4):331-3. PubMed ID: 3465425 [Abstract] [Full Text] [Related]